Search Results - Jill S. Clancy

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial

    Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial by Brian I. Rini, Joaquim Bellmunt, Jill S. Clancy, Kongming Wang, Andreas G. Niethammer, Hariharan Subramanian, Bernard Escudier

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma

    Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma by Birgit Geoerger, Mark W. Kieran, Stephan A. Grupp, Danuta Perek, Jill S. Clancy, Mizue Krygowski, Revathi Ananthakrishnan, Joseph Boni, Anna Berkenblit, Sheri L. Spunt

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors

    Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors by Sheri L. Spunt, Stephan A. Grupp, Terry A. Vik, Victor M. Santana, David J. Greenblatt, Jill S. Clancy, Anna Berkenblit, Mizue Krygowski, Revathi Ananthakrishnan, Joseph Boni, Richard J. Gilbertson

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial

    Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial by Alice T. Shaw, Enriqueta Felip, Todd M. Bauer, Benjamin Besse, Alejandro Navarro, Sophie Postel‐Vinay, Justin F. Gainor, Melissa L. Johnson, Jörg Dietrich, Leonard P. James, Jill S. Clancy, Joseph Chen, Jean‐François Martini, Antonello Abbattista, Benjamin Solomon

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    <i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer

    <i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer by Alice T. Shaw, Benjamin Solomon, Benjamin Besse, Todd M. Bauer, Chia‐Chi Lin, Ross A. Soo, Gregory J. Riely, Sai‐Hong Ignatius Ou, Jill S. Clancy, Sherry Li, Antonello Abbattista, Holger Thurm, Miyako Satouchi, D. Ross Camidge, Steven Kao, Rita Chiari, Shirish M. Gadgeel, Enriqueta Felip, Jean‐François Martini

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: